Common Equity: The sum of all common equity items.
Dare Bioscience, Inc. (DARE) had Common Equity of $-9.56M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
$0.03M |
|
$-4.38M |
|
-- |
|
$0.03M |
|
$4.61M |
|
$-4.58M |
|
$0.20M |
|
$-4.38M |
|
$-4.38M |
|
$-4.38M |
|
$-4.38M |
|
$-4.38M |
|
$-4.38M |
|
$-4.58M |
|
$-4.41M |
|
8.76M |
|
8.76M |
|
$-0.50 |
|
$-0.50 |
|
| Balance Sheet Financials | |
$11.82M |
|
$1.48M |
|
$6.80M |
|
$18.62M |
|
$21.19M |
|
$0.65M |
|
$6.99M |
|
$28.18M |
|
|
Common Equity |
$-9.56M |
$-9.56M |
|
$-9.56M |
|
8.85M |
|
| Cash Flow Statement Financials | |
$-5.47M |
|
$-0.16M |
|
$0.25M |
|
$16.00M |
|
$10.63M |
|
$-5.37M |
|
$0.38M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.56 |
|
-- |
|
-- |
|
-0.07 |
|
-0.25 |
|
100.00% |
|
-18016.75% |
|
-18016.75% |
|
-- |
|
-17219.12% |
|
-17219.12% |
|
$-5.63M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
0.24 |
|
372.48 |
|
45.78% |
|
45.78% |
|
-23.52% |
|
49.12% |
|
$-1.08 |
|
$-0.64 |
|
$-0.62 |
|